fluoxetine has been researched along with Fasting Hypoglycemia in 9 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Fasting Hypoglycemia: HYPOGLYCEMIA expressed in the postabsorptive state, after prolonged FASTING, or an overnight fast.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study demonstrated that 6 weeks' administration of the SSRI fluoxetine can amplify a wide spectrum of ANS and metabolic counterregulatory responses during hypoglycemia in healthy individuals." | 9.13 | Effects of a selective serotonin reuptake inhibitor, fluoxetine, on counterregulatory responses to hypoglycemia in healthy individuals. ( Briscoe, VJ; Davis, SN; Dawling, S; Ertl, AC; Tate, DB, 2008) |
| "Previous work has demonstrated that chronic administration of the serotonin reuptake inhibitor (SSRI) fluoxetine augments counterregulatory responses to hypoglycemia in healthy humans." | 9.13 | Effects of the selective serotonin reuptake inhibitor fluoxetine on counterregulatory responses to hypoglycemia in individuals with type 1 diabetes. ( Briscoe, VJ; Davis, SN; Ertl, AC; Tate, DB, 2008) |
| " We report a patient with persistent congenital hyperinsulinism (CHI) who developed recurrent hypoglycaemia following fluoxetine therapy." | 7.83 | Fluoxetine-Induced Hypoglycaemia in a Patient with Congenital Hyperinsulinism on Lanreotide Therapy. ( Didi, M; Giri, D; Price, V; Senniappan, S; Yung, Z, 2016) |
| "A 17-year-old boy with type 1 diabetes mellitus developed new loss of hypoglycemia awareness while being treated with fluoxetine hydrochloride for depression." | 7.70 | Loss of hypoglycemia awareness in an adolescent with type 1 diabetes mellitus during treatment with fluoxetine hydrochloride. ( Burgart, V; Sawka, AM; Zimmerman, D, 2000) |
| "This study demonstrated that 6 weeks' administration of the SSRI fluoxetine can amplify a wide spectrum of ANS and metabolic counterregulatory responses during hypoglycemia in healthy individuals." | 5.13 | Effects of a selective serotonin reuptake inhibitor, fluoxetine, on counterregulatory responses to hypoglycemia in healthy individuals. ( Briscoe, VJ; Davis, SN; Dawling, S; Ertl, AC; Tate, DB, 2008) |
| "Previous work has demonstrated that chronic administration of the serotonin reuptake inhibitor (SSRI) fluoxetine augments counterregulatory responses to hypoglycemia in healthy humans." | 5.13 | Effects of the selective serotonin reuptake inhibitor fluoxetine on counterregulatory responses to hypoglycemia in individuals with type 1 diabetes. ( Briscoe, VJ; Davis, SN; Ertl, AC; Tate, DB, 2008) |
| " We report a patient with persistent congenital hyperinsulinism (CHI) who developed recurrent hypoglycaemia following fluoxetine therapy." | 3.83 | Fluoxetine-Induced Hypoglycaemia in a Patient with Congenital Hyperinsulinism on Lanreotide Therapy. ( Didi, M; Giri, D; Price, V; Senniappan, S; Yung, Z, 2016) |
| "To evaluate the ability of Rosmarinus officinalis hydroalcoholic extract (ROHE), as compared to the positive control fluoxetine, to reverse behavioral (hyperactivity, anhedonic behavior and learning deficit in water maze) and biochemical alterations (serum glucose level and acetylcholinesterase, AChE, activity) induced by an animal model of depression, the olfactory bulbectomy (OB) in mice." | 3.78 | Rosmarinus officinalis L. hydroalcoholic extract, similar to fluoxetine, reverses depressive-like behavior without altering learning deficit in olfactory bulbectomized mice. ( Balen, GO; Bettio, LE; Brocardo, PS; Colla, AR; Cunha, MP; Dalmarco, JB; Grando, J; Machado, DG; Neis, VB; Pizzolatti, MG; Prediger, RD; Rial, D; Rodrigues, AL, 2012) |
| "A 17-year-old boy with type 1 diabetes mellitus developed new loss of hypoglycemia awareness while being treated with fluoxetine hydrochloride for depression." | 3.70 | Loss of hypoglycemia awareness in an adolescent with type 1 diabetes mellitus during treatment with fluoxetine hydrochloride. ( Burgart, V; Sawka, AM; Zimmerman, D, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giri, D | 1 |
| Price, V | 1 |
| Yung, Z | 1 |
| Didi, M | 1 |
| Senniappan, S | 1 |
| Briscoe, VJ | 2 |
| Ertl, AC | 2 |
| Tate, DB | 2 |
| Dawling, S | 1 |
| Davis, SN | 2 |
| Machado, DG | 1 |
| Cunha, MP | 1 |
| Neis, VB | 1 |
| Balen, GO | 1 |
| Colla, AR | 1 |
| Grando, J | 1 |
| Brocardo, PS | 1 |
| Bettio, LE | 1 |
| Dalmarco, JB | 1 |
| Rial, D | 1 |
| Prediger, RD | 1 |
| Pizzolatti, MG | 1 |
| Rodrigues, AL | 1 |
| Deeg, MA | 1 |
| Lipkin, EW | 1 |
| Fernández López, MI | 1 |
| Sánchez Esteban, J | 1 |
| Jímenez Belló, J | 1 |
| Meseguer Zaragoza, A | 1 |
| Palop Larrea, V | 1 |
| Catalán Oliver, C | 1 |
| López-Martín, JM | 1 |
| Martínez Mir, I | 1 |
| Sawka, AM | 1 |
| Burgart, V | 1 |
| Zimmerman, D | 1 |
| Lear, J | 1 |
| Burden, AC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Hypoglycemia Associated Autonomic Failure in Type 1 DM, Question 6[NCT00592670] | 48 participants (Actual) | Interventional | 2005-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for fluoxetine and Fasting Hypoglycemia
| Article | Year |
|---|---|
Effects of a selective serotonin reuptake inhibitor, fluoxetine, on counterregulatory responses to hypoglycemia in healthy individuals.
Topics: 3-Hydroxybutyric Acid; Adult; Alanine; Autonomic Nervous System; Blood Glucose; Blood Pressure; Fatt | 2008 |
Effects of the selective serotonin reuptake inhibitor fluoxetine on counterregulatory responses to hypoglycemia in individuals with type 1 diabetes.
Topics: Adult; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Fluoxetine; Homeostasis; Humans; Hypo | 2008 |
7 other studies available for fluoxetine and Fasting Hypoglycemia
| Article | Year |
|---|---|
Fluoxetine-Induced Hypoglycaemia in a Patient with Congenital Hyperinsulinism on Lanreotide Therapy.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Antineoplastic Agents; Congenital Hyperinsulin | 2016 |
Rosmarinus officinalis L. hydroalcoholic extract, similar to fluoxetine, reverses depressive-like behavior without altering learning deficit in olfactory bulbectomized mice.
Topics: Acetylcholinesterase; Animals; Antidepressive Agents; Behavior, Animal; Blood Glucose; Depression; E | 2012 |
Hypoglycemia associated with the use of fluoxetine.
Topics: Antidepressive Agents, Second-Generation; Depression; Diabetes Mellitus, Type 2; Fluoxetine; Humans; | 1996 |
[Suggestive episodes of hypoglycemia related to fluoxetine].
Topics: Adult; Diabetes Mellitus, Type 2; Diagnosis, Differential; Dizziness; Female; Fluoxetine; Humans; Hy | 1996 |
[Adverse reactions and drugs: the wrong title and content].
Topics: Fluoxetine; Humans; Hypoglycemia; Selective Serotonin Reuptake Inhibitors | 1997 |
Loss of hypoglycemia awareness in an adolescent with type 1 diabetes mellitus during treatment with fluoxetine hydrochloride.
Topics: Adolescent; Awareness; Depression; Diabetes Mellitus, Type 1; Fluoxetine; Humans; Hypoglycemia; Male | 2000 |
Fluoxetine side-effects mimicking hypoglycaemia.
Topics: Adult; Diabetes Mellitus, Type 1; Diagnosis, Differential; Female; Fluoxetine; Humans; Hypoglycemia | 1992 |